Never heard of a CAGR of 141%... Comparison of select biotechs and projected CAGR thru 2017: Biotech as a whole 8.7% AMGN 4% BIIB 17.8% CELG 25.5% GILD 30% ARIA 141% ONXX 38% REGN 16.2% UTHR 7.6% One of these is not like the others. By the way, assuming a PE of around 25-30, a CAGR of 141% would turn current pps into $300 by YE'17.